Oncogenes and antioncogenes in lung tumorigenesis

Chest

Volumn 109, Issue 5 SUPPL., 1996, Pages 130S-134S

  Giaccone, Giuseppe ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

CONFERENCE PAPER; GENE FREQUENCY; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC MARKER; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; ONCOGENE RAS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL DIFFERENTIATION; CHROMOSOME DELETION; DNA, NEOPLASM; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; ONCOGENES; PROGNOSIS;

EID: 0029868889     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.5_Supplement.130S     Document Type: Article

References (46)

1. Gazdar AF, Carbone DP. The biology and molecular genetics of lung cancer. Austin, Tex: RG Landes, 1994
2. Penno MB, August JT, Baylin SB, et al. Expression of CD44 in human lung tumors. Cancer Res 1994; 54:1381-87
3. Tsai CM, Chang KT, Perng RP, et al. Correlation of intrinsic chemoresistance of non-small cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. J Natl Cancer Inst 1993; 85:897-901
4. Lowe SW, Bodis S, McClatchey A, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266:807-10
5. Pfeifer A, Mark GE, Malan-Shibley L, et al. Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of SV40 T-antigen immortalized human bronchial epithelial cells. Proc Natl Acad Sci USA 1989; 86:10075-79
6. Amstad P, Reddel RR, Pfeifer A, et al. Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral Harvey ras. Mol Carcinog 1988; 1:151-60
7. Noguchi M, Murakami M, Bennett W, et al. Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. Cancer Res 1993; 53:2035-43
8. Gerwin BI, Spillare E, Forrester K, et al. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor type B1. Proc Natl Acad Sci USA 1992; 89:2759-63
9. Mitsudomi T, Viallet J, Mulshine JL, et al. Mutations of ras genes distinguish a subset of non-small cell lung cancer cell lines from small cell lung cancer cell lines. Oncogene 1991; 6:1353-62
10. Bos J. ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4682-89
11. Kern JA, Schwartz DA, Nordberg JE, et al. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990; 50:5184-87
12. Nigro J, Baker S, Preisinger A, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342:705-08
13. Chiba I, Takahashi T, Nau MM, et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 1990; 5:1603-10
14. Finlay C, Hinds P, Levine AJ. The p53 protooncogene can act as a suppressor of transformation. Cell 1989; 57:1083-93
15. Harbour JW, Lai S-L, Whang-Peng J, et al. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241:353-57
16. Whang-Peng J, Kao-Shan C, Lee E, et al. A specific chromosome defect associated with human small cell lung cancer: deletion 3p(14-23). Science 1982; 215:181-82
17. Yokota J, Wada M, Shimosato Y, et al. Loss of heterozygosity on chromosomes 3, 13, and 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 1987; 84:9252-56
18. Brennan J, O'Connor T, Makuch RW, et al. myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res 1991; 51:1708-12
19. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 1993; 329:690-94
20. Slebos RJ, Kibbelaar RE, Dalesio O, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323:561-65
21. Mitsudomi T, Steinberg SM, Oie HK, et al. ras gene mutations in non-small cell lung cancers are associated with shortened survival, irrespective of treatment intent. Cancer Res 1991; 51:4999-5002
22. Sugio K, Ishida T, Yokoyama H, et al. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 1992; 52:2903-06
23. Harada M, Dosaka-Aldta H, Miyamoto H, et al. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer. Cancer 1992; 69:72-7
24. Testa JR, Siegfried JM. Chromosome abnormalities in human non-small cell lung cancer. Cancer Res 1992; 52:2702s-06s
25. Shiseki M, Kohno T, Nishikawa R, et al. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 1994; 54:5643-48
26. Ried T, Petersen I, Holtgreve-Grez H, et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 1994; 54:1801-06
27. Marshall CJ. Tumor suppressor genes. Cell 1991; 64:313-26
28. Carritt B, Kok K, van den Berg A, et al. A gene from human chromosome region 3p21 with reduced expression in small cell lung cancer. Cancer Res 1992; 52:1536-41
29. Yokoyama S, Yamakawa K, Tsuchiya E, et al. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1992; 52:873-77
30. Olopade OJ, Buchhagen DL, Malik K, et al. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 1993; 53(suppl 10):2410-15
31. Mead LJ, Gillespie MT, Irving LB, et al. Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res 1994; 54:2307-09
32. Merlo A, Gabrielson E, Askin F, et al. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994; 54:640-42
33. Merlo A, Gabrielson E, Mabry M, et al. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res 1994; 54:2322-26
34. Hosoe S, Ueno K, Shigedo Y, et al. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res 1994; 54:1787-90
35. D'Amico D, Carbone DP, Johnson BE, et al. Polymorphic sites within the MMC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res 1992; 52:1996-99
36. Carbone DP, Mitsudomi T, Chiba I, et al. p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer: a preliminary report of LCSG 871. Chest 1994; 106(suppl 6):377s-81s
37. Quinlan DC, Davidson AG, Summers CL, et al. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992; 52:4828-31
38. Horio Y, Takahashi T, Kuroishi T, et al. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res 1993; 53:1-4
39. Ebina M, Steinberg SM, Mulshine JL, et al. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res 1994; 54:2496-2503
40. Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994; 54:1634-37
41. Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992; 52:6079-82
42. Klein N, Vignoud JM, Sadmi M, et al. Squamous metaplasia expression of protooncogenes and p53 in lung cancer patients. Lab Invest 1993; 68:26-32
43. Bennett WP, Colby TV, Travis WD, et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993; 53:4817-22
44. Sugio K, Kishimoto Y, Virmani AK, et al. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 1994; 54:5811-15
45. Miller AD. Human gene therapy comes of age. Nature 1992; 357:455-60
46. Fujiwara T, Grimm EA, Mukhopadhayay T, et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994; 54:2287-91